VG Life Sciences Notes Major Achievements and New Grants in Third Quarter 2015

SANTA BARBARA, Calif., Oct. 8, 2015 /PRNewswire/ — Dear Shareholders, Here at VG Life Sciences (OTC-QB: VGLS), our mission is to save and improve lives through the development of transformative treatments for cancer, infectious diseases, and the chronic inflammation intrinsic to autoimmune diseases. We have made significant progress in a number of areas in the third…